血管内皮抑制素联合放疗对人鼻咽癌细胞CNE-2的体外实验研究
本文选题:重组人血管内皮抑制素(恩度) + 放疗增敏 ; 参考:《昆明医学院》2010年硕士论文
【摘要】: 【目的】观察血管内皮抑制素(恩度)联合放疗对人鼻咽癌细胞系(CNE2)的增殖抑制和诱导细胞凋亡的作用,及其对细胞周期的影响。为血管内皮抑制素对鼻咽癌放疗增敏的可行性提供实验依据。 【方法】四噻唑蓝比色试验(MTT)观察不同浓度的血管内皮抑制素对鼻咽癌CNE2浓度时间抑制作用,计算出最适浓度。四噻唑蓝比色试验(MTT)法观察血管内皮抑制素联合放疗对鼻咽癌CNE2时间抑制作用,以流式细胞术检测对其细胞凋亡和周期的影响。 【结果】1.血管内皮抑制素处理后,用倒置显微镜观察恩度处理后的鼻咽癌细胞,发现随药物及作用时间的增加,CNE2癌细胞逐渐变圆浮起,折光度降低,细胞间连接松散,增殖减慢。 2.MTT法检测不同浓度的恩度在不同时间点对CNE2的增殖抑制作用。不同浓度恩度作用于鼻咽癌细胞CNE2,随着抑制剂作用浓度增加、作用时间的延长,肿瘤细胞存活率逐步降低。 3.单次放疗剂量4Gy,恩度在浓度100mg/1的时候,综合治疗对鼻咽癌细胞CNE2的综合作用强,综合作用比单独用药或者放疗作用强,随时间的增加,肿瘤细胞的存活率逐步降低。 4.流式细胞分析显示:人鼻咽癌细胞CNE2胞凋亡率与G2/M期百分率呈负相关,恩度可能增加了细胞G2/M的放射敏感性。 5.TdT介导的dUTP缺口末端标记技术(TUNEL)法检测细胞凋亡:恩度浓度为100mg/1,单次剂量4Gy,作用72h,以PI双染色法流式细胞仪测定细胞凋亡率和坏死率,对照组细胞凋亡率仅为1.7%,细胞坏死率为8.1%,实验组细胞凋亡率为11.6%。 【结论】1.一定浓度的血管内皮抑制素对人鼻咽癌细胞系(CNE2)有抑制作用,作用呈时间浓度依耐性。 2.血管内皮抑制素联合放疗对人鼻咽癌细胞系(CNE2)有增敏作用,呈时间依耐性。
[Abstract]:[objective] to observe the effects of vascular endothelial inhibitor (Endothelin) combined with radiotherapy on the proliferation and apoptosis of human nasopharyngeal carcinoma cell line (CNE2) and its effect on cell cycle. [methods] MTT assay was used to observe the time inhibitory effect of different concentrations of vascular endothelin on CNE2 concentration in nasopharyngeal carcinoma (NPC). The optimum concentration is calculated. MTT assay was used to observe the inhibitory effect of vascular endothelial inhibitor combined with radiotherapy on CNE2 of nasopharyngeal carcinoma, and the effect of flow cytometry on apoptosis and cell cycle of nasopharyngeal carcinoma. [results] 1. After treatment with vascular endothelin, nasopharyngeal carcinoma cells treated with Endosterone were observed by inverted microscope. With the increase of drug and time of action, CNE2 cancer cells gradually became round and floating, the diopter decreased, and the intercellular junctions were loosely connected. 2. MTT assay was used to detect the inhibitory effect of different concentrations of Endox on CNE2 at different time points. The survival rate of nasopharyngeal carcinoma cell line CNE _ 2 decreased gradually with the increase of the concentration of inhibitor and the prolongation of the action time. When the dose of single dose of radiotherapy was 4 Gy, the comprehensive effect of combined therapy on nasopharyngeal carcinoma cell line CNE2 was stronger than that of single dose of radiotherapy or radiotherapy at the concentration of 100mg/1, and the effect increased with time. The survival rate of tumor cells decreased gradually. 4. 4. Flow cytometry showed that the apoptosis rate of CNE2 cells was negatively correlated with the percentage of G _ 2 / M phase. TDT mediated dUTP Nick end labeling (Tunel) assay was used to detect apoptosis: Endol concentration was 100 mg / 1, single dose was 4 Gy, contact time was 72 h, flow fine flow was detected by Pi double staining. Cell apoptosis rate and necrosis rate were measured by cell analyzer. In the control group, the apoptosis rate was only 1.7%, the necrosis rate was 8.1%, and the apoptotic rate in the experimental group was 11.6%. [conclusion] 1. A certain concentration of vascular endothelin inhibited human nasopharyngeal carcinoma (CNE2) cell line (CNE2), the effect showed time concentration dependent tolerance. Endotheliostatin combined with radiotherapy can enhance the sensitivity of human nasopharyngeal carcinoma cell line (CNE2) with time dependent tolerance.
【学位授予单位】:昆明医学院
【学位级别】:硕士
【学位授予年份】:2010
【分类号】:R739.63
【参考文献】
相关期刊论文 前10条
1 刘宇,张幸平,陈晓品,徐曼,李圆圆;鼻咽鳞癌组织中p53和bcl-2蛋白的表达及临床意义[J];肿瘤防治杂志;2005年01期
2 张磊;刁鹏;黄建鸣;李涛;查晓;郎锦义;;放射线联合人血管内皮生长抑素对HNE1鼻咽癌移植瘤生长抑制作用[J];肿瘤预防与治疗;2008年01期
3 高洪彬;姚运红;;鼻咽癌放射增敏的研究进展[J];实用癌症杂志;2008年01期
4 袁健,孙宁;鼻咽癌细胞系CNE-2Z放射敏感性异质性与凋亡的关系[J];实用肿瘤杂志;2005年03期
5 潘建基;宗井凤;;鼻咽癌放射治疗的现状和相关问题[J];肿瘤学杂志;2007年05期
6 杨惠玲,佘妙容,马志楷,郭辉,郑芹,苏秀容;荷人鼻咽癌裸鼠血内皮抑素的水平变化[J];中国病理生理杂志;2002年10期
7 许婷婷;胡超苏;应红梅;朱国培;吴永如;;西妥昔单抗联合其他治疗方法治疗头颈部鳞癌[J];中国癌症杂志;2008年03期
8 林丽珠;周京旭;张恩欣;黄海福;;恩度联合含培美曲塞方案治疗复发耐药骨肉瘤2例[J];中国肿瘤临床;2007年20期
9 李晓华;彭英;李湘平;刘雄;李刚;;腺相关病毒介导的内皮抑素对鼻咽癌移植瘤生长和转移的抑制作用[J];中华耳鼻咽喉头颈外科杂志;2005年12期
10 谢良喜,李德锐,林英城,林昆,陈炯玉,洪超群;三氧化二砷对鼻咽癌离体细胞的放射增敏作用[J];中华放射医学与防护杂志;2004年03期
,本文编号:2058130
本文链接:https://www.wllwen.com/yixuelunwen/yank/2058130.html